BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22528623)

  • 1. Dermatologic manifestations as indicators of immune status in HIV/AIDS.
    Lutwak N; Dill C
    J Gen Intern Med; 2012 Jul; 27(7):765. PubMed ID: 22528623
    [No Abstract]   [Full Text] [Related]  

  • 2. Dermatologic manifestations as indicators of immune status in HIV/AIDS.
    Levy TH; Jacobson DF
    J Gen Intern Med; 2012 Jan; 27(1):124. PubMed ID: 21647751
    [No Abstract]   [Full Text] [Related]  

  • 3. Mucocutaneous findings in pediatric AIDS related to degree of immunosuppression.
    Wananukul S; Deekajorndech T; Panchareon C; Thisyakorn U
    Pediatr Dermatol; 2003; 20(4):289-94. PubMed ID: 12869145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency, pattern, and extent of skin diseases in relation to CD4+ cell count among adults with human immunodeficiency virus infection or acquired immunodeficiency syndrome in Osogbo, southwestern Nigeria.
    Akinboro AO; Onayemi O; Mejiuni AD
    Int J Dermatol; 2014 Apr; 53(4):416-24. PubMed ID: 24783258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological study of cutaneous manifestations in HIV and AIDS patients.
    Rane SR; Agrawal PB; Kadgi NV; Jadhav MV; Puranik SC
    Int J Dermatol; 2014 Jun; 53(6):746-51. PubMed ID: 24320966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS).
    Kaplan MH; Sadick N; McNutt NS; Meltzer M; Sarngadharan MG; Pahwa S
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 1):485-506. PubMed ID: 2950145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin diseases in children with HIV infection and their association with degree of immunosuppression.
    Lim W; Sadick N; Gupta A; Kaplan M; Pahwa S
    Int J Dermatol; 1990; 29(1):24-30. PubMed ID: 2139434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric HIV/AIDS and the skin: an update.
    Gottschalk GM
    Dermatol Clin; 2006 Oct; 24(4):531-6, vii. PubMed ID: 17010781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression.
    Uthayakumar S; Nandwani R; Drinkwater T; Nayagam AT; Darley CR
    Br J Dermatol; 1997 Oct; 137(4):595-8. PubMed ID: 9390338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of skin disorders with CD4 lymphocyte counts in patients with HIV/AIDS.
    Mignard M; Spira RM; Morlat P; Dabis F; Doutre MS
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 1):298-9. PubMed ID: 9704857
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation of skin disorders with CD4 lymphocyte counts in patients with HIV/AIDS.
    Goldstein B; Berman B; Sukenik E; Frankel SJ
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):262-4. PubMed ID: 9039183
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary tuberculosis in immunocompromised hosts: epidemiological, clinical, and radiological assessment.
    Davis SD; Yankelevitz DF; Williams T; Henschke CI
    Semin Roentgenol; 1993 Apr; 28(2):119-30. PubMed ID: 8516688
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-neoplastic, cutaneous and mucocutaneous manifestations of HIV infection.
    Francis N
    Histopathology; 1993 Oct; 23(4):297-305. PubMed ID: 8300065
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunocompromised cutaneous district and the necessity of a new classification of its disparate causes.
    Caccavale S; Kannangara AP; Ruocco E
    Indian J Dermatol Venereol Leprol; 2016; 82(2):227-9. PubMed ID: 26924409
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of CD4 cell count and antiretroviral therapy on mucocutaneous manifestations among HIV/AIDS patients in Yunnan, China.
    Li YY; Yang SH; Wang RR; Tang JT; Wang HM; Kuang YQ
    Int J Dermatol; 2020 Mar; 59(3):308-313. PubMed ID: 31846069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous manifestations of childhood acquired immunodeficiency syndrome and human immunodeficiency virus infection.
    Whitworth JM; Janniger CK; Oleske JM; Schwartz RA
    Cutis; 1995 Feb; 55(2):62-6, 70-2. PubMed ID: 7729159
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dermatologic diseases in patients with AIDS].
    Meigel W; Kern P; Dietrich M
    Hautarzt; 1986 May; 37(5):250-4. PubMed ID: 3015840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug toxicity or syndrome of immune restoration causing fulminant cirrhosis after HAART-induced immune recovery.
    Murcia JM; Boix V; Merino E; Manso MI; Portilla J
    Eur J Clin Microbiol Infect Dis; 2002 Feb; 21(2):153-5. PubMed ID: 11939401
    [No Abstract]   [Full Text] [Related]  

  • 19. Dermatologic infections in the immunocompromised (non-HIV) host.
    Lopez FA; Sanders CV
    Infect Dis Clin North Am; 2001 Jun; 15(2):671-702, xi. PubMed ID: 11447714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatologic manifestations of AIDS in children.
    Torre D; Zeroli C; Fiori GP; Ferraro G; Speranza F
    Pediatrician; 1991; 18(3):195-203. PubMed ID: 1946086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.